ODTX:NASDAQ, Odyssey Therapeutics Inc.

ODTX stock overview

Odyssey Therapeutics Inc. (ODTX:NASDAQ) closed at $16.96 on November 20, 2026, down 7.52% on the day. The stock trades 41.6% below its 52-week high of $29.05 and 12.3% above its 52-week low of $15.10. Over the past year, it gained 3.3%. Odyssey Therapeutics Inc. is part of the Health Care sector.

Key figures

Price
$16.96
Day change
-7.52%
Volume
677,842
Average volume
321,550
Market cap
815M+
52-week range
$15.10 – $29.05
50-day average
$20.08
200-day average
$19.70

Price action over the past year

In 136 trading sessions since May 11, 2026, ODTX closed higher on 71 days (52%). Its best day was August 19, 2026 (+10.48%) and its worst was October 6, 2026 (-13.00%). The stock moved 10% or more in a single session 6 times.

Recent signals

ODTX news

About Odyssey Therapeutics Inc.

Odyssey Therapeutics is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology. Since its founding in 2021, Odyssey has built a portfolio of completely internally discovered and developed medicines with its first program advancing through multiple clinical milestones. The portfolio leverages the scientific expertise of its team of experienced drug hunters and a comprehensive suite of tools to efficiently advance product candidates that the company believe have the potential to induce deep and durable remission for patients across several inflammatory diseases with unmet need.

Similar stocks

Find more stocks like ODTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.